Elhan Webb | executive |
Richard Paulson | executive |
Reshma Rangwala | executive |
Sohanya Cheng | executive |
Michael Mason | executive |
Peter Lawson | analyst |
Maurice Raycroft | analyst |
Jonathan Chang | analyst |
Colleen Hanley | analyst |
Johoon Kim | analyst |
Stephen Bersey | analyst |
Good morning. My name is Ludy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Elhan Webb, Senior Vice President of Investor Relations. Please go ahead.